Ryo Nakamaru

University of Tokyo

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Masanori Murakami

Institute of Science Tokyo

JAPAN

View details

Shota Yoshida

Osaka University

JAPAN

View details

Hiroki Hayashi

Osaka University

JAPAN

View details

Yasuyuki Shiraishi

Keio University School of Medicine

JAPAN

View details

Shiori Nishimura

University of Tokyo

JAPAN

View details

Takehiro Kimura

Keio University School of Medicine

JAPAN

View details

Hironori Nakagami

Prof.

Osaka University

JAPAN

View details

Yoshinori Katsumata

Keio University School of Medicine

JAPAN

View details

Hiromi Rakugi

JAPAN

View details

Yuji Nagatomo

Associate Proffesor

National Defense Medical College

JAPAN

View details

Shunsuke Katsuki

Kyushu University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ryo Nakamaru

Research Interests

Explore related searches

Contact this professor

Articles (19)

A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts

Age and Health Status Benefits Following Initiation of Atrial Fibrillation‐Specific Treatments

Patterns of Frailty in Newly Diagnosed Older Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation

Risk-Stratified Prognostic Implications of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention

Association of Tricuspid Regurgitation With Mortality in Heart Failure With Left-Sided Heart Disease

Trajectories of Frailty and Clinical Outcomes in Older Adults With Atrial Fibrillation: Insights From the Shizuoka Kokuho Database

Treatment patterns and trajectories in patients after acute heart failure hospitalization

Phenotyping of Elderly Patients With Heart Failure Focused on Noncardiac Conditions: A Latent Class Analysis From a Multicenter Registry of Patients Hospitalized With Heart Failure

Cardiovascular vs. non‐cardiovascular deaths after heart failure hospitalization in young, older, and very old patients

Time Trend in Incidence of Sudden Cardiac Death After Percutaneous Coronary Intervention from 2009 to 2017 (from the Japanese Multicenter Registry)

Temporal Trends in Heart Failure Management and Outcomes: Insights From a Japanese Multicenter Registry of Tertiary Care Centers

Discontinuation of Oral Anticoagulants in Atrial Fibrillation Patients: Impact of Treatment Strategy and on Patients’ Health Status

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults

Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes

Preclinical study of a DNA vaccine targeting SARS-CoV-2

Prevention of Acute Lung Injury by a Novel CD14-Inhibitory Receptor Activator of the NF-κB Ligand Peptide in Mice

Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey.

Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.

A novel angiotensin II peptide vaccine without an adjuvant in mice.

Collaborators (11)

Masanori Murakami

Shota Yoshida

Hiroki Hayashi

Yasuyuki Shiraishi

Shiori Nishimura

Takehiro Kimura

Hironori Nakagami

Yoshinori Katsumata

Hiromi Rakugi

Yuji Nagatomo

Shunsuke Katsuki

Make your next move.